AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue420173235278
Cost of Revenue33,93114,53815,9949,149
Gross Profit-33,511-14,365-15,759-8,871
Operating Expenses
Research Development----
Selling General and Administrative12,0966,9706,2636,890
Non Recurring----
Total Operating Expenses47,48322,98723,81517,560
Operating Income or Loss-47,063-22,814-23,580-17,282
Income from Continuing Operations
Total Other Income/Expenses Net-23,729-4814,973-2,139
Earnings Before Interest and Taxes-47,063-22,814-23,580-17,282
Interest Expense----30
Income Before Tax-70,792-23,295-18,607-19,421
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-70,792-23,295-18,607-19,421
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-70,792-23,295-18,607-19,421
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-70,792-23,295-18,607-19,421